Shots:  A California-based venture capital fund, Samsara Biocapital partners with medical companies and scientists to infuse cutting-edge innovations in medicines  In 2023, Samsara participated in five funding rounds and invested around $2.3B to add 19 companies to its portfolio  For a curated report on a specific investor or venture capital, reach out to us at connect@pharmashots.com …